Diaverum launches AI-powered kidney disease education tool

Swedish renal care provider Diaverum has launched kidney.com, an AI-powered health assistant designed to improve access to kidney health education.

Chronic kidney disease (CKD) is one of the fastest-growing global health challenges and among the most costly chronic diseases for healthcare systems. In the UK, it costs the NHS around £6.4 billion annually.

Rafael Romanini, chief executive of Diaverum, said: “At Diaverum, combining science with compassion for meaningful progress in renal care is at the core of our DNA.

“With kidney.com, we’re extending that philosophy into the digital world, using AI-powered education to make kidney health knowledge accessible, relevant and actionable for everyone, anywhere, 24/7.

“This initiative reflects our broader commitment to helping people live fulfilling lives, while supporting the sustainability of healthcare systems through education, prevention and innovation.”

Studies suggest that well-informed patients are 32% less likely to be hospitalised and 14% less likely to visit emergency departments. However, up to 90% of people are unaware they have CKD until it is at an advanced stage, and many lack the knowledge and resources needed to slow its progression.

The kidney.com platform includes a conversational AI interface trained on clinical sources, with evidence-based content on chronic and acute kidney conditions. Features include voice control, product label interpretation via file upload, and multilingual support. English, French, German, Portuguese and Arabic are currently available, with additional languages planned.

It was developed in collaboration with more than 30 nephrologists, physicians, and nurses spanning 13 countries and by completing over 14,000 chat interactions during the testing phase to ready the platform for real-world use.

Dr Fernando Macário, chief medical officer at Diaverum’s parent company M42, added: “Education has always been at the heart of good medicine. When people understand their condition, they’re more engaged and empowered in their care.

“Evidence consistently shows that this improves adherence, reduces complications, and contributes directly to better outcomes. Kidney.com translates complex, specific renal care knowledge into simple, evidence-based guidance that enhances, not replaces, the vital role of clinicians.

“It supports healthcare teams by fostering informed conversations and shared decision-making, helping doctors deliver more personalized, preventive, and effective care.”

Kidney.com has launched in the UK, France, Germany, Portugal and UAE, with additional markets to follow.